Biosortia Microbiomics

If you are on LinkedIn can you like this post and comment - Please -->

Ross Youngs on LinkedIn: #microbiome #microbiology #drugdiscovery #chemistry #innovation | 14 comments Please Vote for Biosortia by 👍 liking this post and share AND even more points for comments so if you want to see our breakthrough technology obtain important… | 14 comments on LinkedIn

Check out this article - https://medcitynews.com/2023/02/industrial-scale-microbiome-mining-is-a-new-drug-discovery-toolbox/

Keep up to date on LinkedIn.
• https://www.linkedin.com/in/rossyoungs/
• https://www.linkedin.com/company/Biosortia Microbiomics

https://medcitynews.com/2023/02/industrial-scale-microbiome-mining-is-a-new-drug-discovery-toolbox/

Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox Within ten years of ex*****on and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth.

Great Article to start off December!

The Microbiome Miner Water is the giver of life, but could it be a giver of untold medicines too?

Ross Youngs

The Untapped Potential of Microbiome Mining in Drug Discovery and Precision Medicine - Healthcare Business Today Through the innovative practice of microbiome mining, scientists and researchers will be able to harvest and study microbiome molecules at an industrial scale for the first time. Life science is on the verge of ushering in the age of microbiome metabolomics, and it is possible to have a Moore’s la...

Ross Youngs on stage right now 6/2/22 PM Talking to Investors! http://healthcarecapitalmarkets.com/

Check out the new WEBSITE at

Big news Matthew Bertin and Ross Youngs https://patch.com/rhode-island/narragansett/uri-study-reduce-neuroinflammation-progresses

URI Study to Reduce Neuroinflammation Progresses One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.)

Big algae blooms at GLSM, Celina, OH 7/22/2021 https://www.facebook.com/groups/161922801167/permalink/10159266761001168/

Huge Microbiome Industry Deal $!! -- Deal calls for more than $500 million in upfront and contingent milestone payments https://www.businesswire.com/news/home/20210701005405/en/Seres-Therapeutics-Nestl%C3%A9-Health-Science-Announce-SER-109-Co-Commercialization-License-Agreement

Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement with Nestlé

https://algaeplanet.com/microalgal-derived-compounds-that-fight-viruses/

Microalgal-derived Compounds that Fight Viruses Researchers in Italy studied microalgal-derived compounds that suggest the potential antiviral benefits of a diet enriched with microalgae.

Big industry news....https://www.businesswire.com/news/home/20210528005298/en/Accelerator-Life-Science-Partners%E2%80%99-Portfolio-Company-Lodo-Therapeutics-Acquired-by-Zymergen-Inc.

Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc. Accelerator Life Science Partners (“ALSP”), a leading early-stage life science accelerator and investment firm, today announced that its portfolio com

From OhioX today 3/29- Ross Youngs- Founder

We're excited to welcome Biosortia, Inc. - Microbiomics to OhioX!

Biosortia Microbiomics, of Dublin, directly obtains previously impossible but highly sought after small-molecules from microbes for new drug therapies. Biosortia’s massive scale processing will drive a rapidly expanding intellectual property and data portfolio resulting in an ever growing pipeline of opportunities for sales, licensing, and services for high value customers.

https://www.ohiox.org/members/biosortia-microbiomics

Member Profile: Biosortia Microbiomics — OhioX Biosortia Microbiomics, of Dublin, directly obtains previously impossible but highly sought after small-molecules from microbes for new drug therapies. Biosortia’s massive scale processing will drive a rapidly expanding intellectual property and data portfolio resulting in an ever growing pipeline...

Save the date- Wednesday, January 27, 2021
01:30 PM - 07:30 PM PT Ross Youngs and Biosortia Pharmaceuticals looking to set 1:1 virtual networking meetings (info & sign-up) https://www.mitcnc.org/events/future-of-healthcare-and-medicine-2021-conference/

Future of Healthcare & Medicine Conference MITCNC Future of Healthcare & Medicine '21 Learn from founders, technologists, investors, and industry leaders from MIT and beyond, working to build the future of healthcare & medicine. Choose from 7 live panels on AI, psychedelics, COVID, digital health, and more. Join us on January

Save the Date- 2/23/2021 Biosortia Pharmaceuticals to present (sign-up at) https://lnkd.in/eF6kC2y Topic: [Addressing Chemistry Within the Plant-Soil Microbiome]
Aquatic Microbiome As A Surrogate Microbiome For New Chemistry For Sustainable Agriculture
by: Ross Youngs, Chief Executive Officer, Biosortia Pharmaceuticals

5th Microbiome Movement - AgBioTech Summit | Digital Event 3 day conference focusing on discovering, translating and commercializing the plant-soil microbiome into next generation agbiologicals

From Ross Youngs-Founder- "Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approaches. Biosortia is seeking partners interested in accessing compounds and chemistries to develop biologically relevant small molecule leads."

This graphic shows a representation of the finite small molecules nature has in its arsenal of chemistry vs. the infinite calculable possibilities of what would be possible. The difference is major to understanding why pharma research has dramatically driven the costs of a 'real' new drug. Nature is very efficient overtime and these small molecules are the target-hitting molecules hidden from researchers.

https://lnkd.in/e7dt_Et


Nature Magazine Article Biosortia Dec 2020

Biosortia—at scale mining of nature’s metabolite bounty Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approac...

Starting Monday (On Demand)! October 26–29, 2020

(European Standard Time) Ross Youngs & Biosortia presenting at (virtual)

Topic- Small molecule mining of human surrogate microbiome for therapeutics-Technological breakthroughs now allow obtaining natural microbiome and interrogating the actual hidden chemistry along with the genomics.
Direct and indirect support for therapeutic opportunities emerging from natural environmental microbiome habitats is evidenced by drugs on the market or candidates in the pipeline and genomic and metabolic pathway overlap to various human microbiome

https://informaconnect.com/bioeurope/microbiome-therapeutics-us/

Microbiome Therapeutics US | BIO-Europe BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend.....

Ross Youngs Save the dates-[Virtual!] 30th Nov -1st Dec 2020
Start Time 08:15 (GMT, UTC) ! Ross Youngs and Biosortia Pharmaceuticals
presenting on (Title): Microorganisms are unrivalled producers of bioactive small molecules. Biosortia’s technology explores and accesses microbiomes at massive scale to identify novel small molecule chemistry for next generation therapeutics & crop health http://www.global-engage.com/event/microbiota/

Ross Youngs virtually from Berlin, Germany tomorrow! Web: www.vonlanthengroup.com

SAVE THE DATES & sign-up!- MICROBIOME THERAPEUTICS US 2020/Bio-Europe- October 26–29, 2020 Youngs and Pharmaceuticals presenting - Small Molecule Mining of Human Surrogate Microbiome for Therapeutics
https://informaconnect.com/bioeurope/microbiome-therapeutics-us/

Microbiome Therapeutics US | BIO-Europe BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend.....